Published in J Antimicrob Chemother on February 20, 2012
Risk factors for a low linezolid trough plasma concentration in acute infections. Antimicrob Agents Chemother (2013) 0.99
Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta-analysis. Crit Care (2013) 0.83
Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials. Eur J Clin Microbiol Infect Dis (2013) 0.81
Breakthrough bacteremia by linezolid-susceptible Enterococcus faecalis under linezolid treatment in a severe polytrauma patient. Antimicrob Agents Chemother (2013) 0.80
Antibiotic therapy of pneumonia in the obese patient: dosing and delivery. Curr Opin Infect Dis (2014) 0.77
Therapeutic drug monitoring: linezolid too? Crit Care (2014) 0.77
Overview of progresses in critical care medicine 2012. J Thorac Dis (2013) 0.76
Proper use of antibiotics: situation of linezolid at the intensive care unit of the Tunisian Military Hospital. Pan Afr Med J (2016) 0.75
Linezolid dose that maximizes sterilizing effect while minimizing toxicity and resistance emergence for tuberculosis. Antimicrob Agents Chemother (2017) 0.75
A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med (2013) 6.91
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care (2013) 3.90
Patient Mortality Is Associated With Staff Resources and Workload in the ICU: A Multicenter Observational Study. Crit Care Med (2015) 3.49
Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality. Crit Care Med (2011) 3.43
Laryngeal injuries and intubating conditions with or without muscular relaxation: an equivalence study. Can J Anaesth (2008) 2.78
De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial. Intensive Care Med (2014) 2.77
Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia. Crit Care Med (2005) 2.61
L-alanyl-L-glutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: the French controlled, randomized, double-blind, multicenter study. Crit Care Med (2006) 2.51
Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia. Crit Care Med (2003) 2.40
Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases. Intensive Care Med (2015) 2.25
Early identification of patients at risk for difficult intubation in the intensive care unit: development and validation of the MACOCHA score in a multicenter cohort study. Am J Respir Crit Care Med (2013) 1.90
Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int (2011) 1.87
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients. Crit Care (2011) 1.78
Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia. Crit Care Med (2008) 1.75
Reliability of mini-bronchoalveolar lavage for the measurement of epithelial lining fluid concentrations of tobramycin in critically ill patients. Intensive Care Med (2007) 1.64
Simultaneous determination of five systemic azoles in plasma by high-performance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal (2009) 1.63
High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Nephrol Dial Transplant (2008) 1.63
Variable compliance with clinical practice guidelines identified in a 1-day audit at 66 French adult intensive care units. Crit Care Med (2012) 1.60
Activated partial thromboplastin time waveform analysis: a new tool to detect infection? Crit Care Med (2006) 1.59
Background infusion is not beneficial during labor patient-controlled analgesia with 0.1% ropivacaine plus 0.5 microg/ml sufentanil. Anesthesiology (2004) 1.55
Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patients. Antimicrob Agents Chemother (2002) 1.54
Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator-associated pneumonia. Anesthesiology (2002) 1.49
Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma. Crit Care (2010) 1.48
Real-time detection of gastric insufflation related to facemask pressure-controlled ventilation using ultrasonography of the antrum and epigastric auscultation in nonparalyzed patients: a prospective, randomized, double-blind study. Anesthesiology (2014) 1.46
How the relationships between general practitioners and intensivists can be improved: the general practitioners' point of view. Crit Care (2010) 1.45
N-acetylcysteine is effective for prevention but not for treatment of folic acid-induced acute kidney injury in mice. Crit Care Med (2011) 1.41
Prediction of hemodynamic reactivity during total intravenous anesthesia for suspension laryngoscopy using Analgesia/Nociception Index (ANI): a prospective observational study. Minerva Anestesiol (2014) 1.41
[The electroencephalogram is not an adequate test to confirm the diagnosis of brain death]. Can J Anaesth (2007) 1.40
Association between hypernatraemia acquired in the ICU and mortality: a cohort study. Nephrol Dial Transplant (2010) 1.37
Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury (2010) 1.36
Virological, intracellular and plasma pharmacological parameters predicting response to lopinavir/ritonavir (KALEPHAR study). AIDS (2004) 1.35
Bactericidal antibiotics temporarily increase inflammation and worsen acute kidney injury in experimental sepsis. Crit Care Med (2012) 1.33
Portal venous gas detected on computed tomography in emergency situations: surgery is still necessary. World J Surg (2007) 1.32
Plasma and lung concentrations of ceftazidime administered in continuous infusion to critically ill patients with severe nosocomial pneumonia. Intensive Care Med (2004) 1.23
Point-of-care ultrasound in intensive care units: assessment of 1073 procedures in a multicentric, prospective, observational study. Intensive Care Med (2015) 1.22
Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Crit Care (2013) 1.20
Virological responses to atazanavir-ritonavir-based regimens: resistance-substitutions score and pharmacokinetic parameters (Reyaphar study). Antivir Ther (2006) 1.19
Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med (2010) 1.18
Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS One (2012) 1.13
Concomitant assessment of PSP and NT-proCNP as predictive markers of sepsis in severe trauma patients under mechanical ventilation. Crit Care (2013) 1.12
Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study). AIDS (2002) 1.11
Pitfalls in chronobiology: a suggested analysis using intrathecal bupivacaine analgesia as an example. Anesth Analg (2010) 1.08
HIV-1 resistance patterns to integrase inhibitors in antiretroviral-experienced patients with virological failure on raltegravir-containing regimens. J Antimicrob Chemother (2010) 1.08
Severe metabolic or mixed acidemia on intensive care unit admission: incidence, prognosis and administration of buffer therapy. A prospective, multiple-center study. Crit Care (2011) 1.08
Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia. Intensive Care Med (2006) 1.06
Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study. Crit Care (2013) 1.03
Prospective evaluation of nonenhanced MR imaging in acute pancreatitis. J Magn Reson Imaging (2007) 1.03
Protonation equilibrium and lipophilicity of moxifloxacin. J Pharm Biomed Anal (2005) 1.02
Blood purification in sepsis: a new paradigm. Contrib Nephrol (2010) 1.01
Simultaneous determination of the antiretroviral agents: amprenavir, lopinavir, ritonavir, saquinavir and efavirenz in human peripheral blood mononuclear cells by high-performance liquid chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 1.01
Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade. Med Mycol (2012) 1.00
Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failure. Am J Respir Crit Care Med (2013) 0.99
Risk factors for airway complications during general anaesthesia in paediatric patients. Paediatr Anaesth (2002) 0.98
Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric). Intensive Care Med (2015) 0.98
Early- and late-onset ventilator-associated pneumonia acquired in the intensive care unit: comparison of risk factors. J Crit Care (2007) 0.97
Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia. Intensive Care Med (2004) 0.97
Virological and immunological response in HIV-1-infected patients with multiple treatment failures receiving raltegravir and optimized background therapy, ANRS CO3 Aquitaine Cohort. J Antimicrob Chemother (2009) 0.96
Site specific alterations of adipose tissue mitochondria in 3'-azido-3'-deoxythymidine (AZT)-treated rats: an early stage in lipodystrophy? Biochem Pharmacol (2005) 0.96
Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell model. Antimicrob Agents Chemother (2002) 0.94
Interpretation of genotype and pharmacokinetics for resistance to fosamprenavir-ritonavir-based regimens in antiretroviral-experienced patients. Antimicrob Agents Chemother (2007) 0.94